Close X
Saturday, November 23, 2024
ADVT 
International

Afghan Prez fled with 4 cars and a helicopter filled with cash

Darpan News Desk IANS, 16 Aug, 2021 12:35 PM
  • Afghan Prez fled with 4 cars and a helicopter filled with cash

New Delhi, Aug 16 (IANS) The Russian Embassy in Kabul has said that Afghanistan President Ashraf Ghani had fled the country with four cars and a helicopter full of cash and had to leave some money behind as it would not fit in, the RIA news agency reports.

Nikita Ishchenko, a spokesman for the Russian Embassy in Kabul, was quoted as saying by RIA: "Four cars were full of money, they tried to stuff another part of the money into a helicopter, but not all of it fit. And some of the money was left lying on the tarmac."

Ischenko confirmed his comments to a global news wire, citing "witnesses" as the source of his information, Al Jazeera reported.

Afghanistan Defence Minister Bismillah Mohammadi said in a tweet, in an apparent reference to Ghani and his associates, that they "tied our hands behind our backs and sold the homeland, damn the rich man and his gang."

Senior Afghan leader and Head of the High Council for National Reconciliation, Abdullah Abdullah, had said in a video clip that Ghani has left Afghanistan.

He said that Ghani left the people of Afghanistan in mess and misery and he will be judged by the nation.

VOA reported that Ghani, along with his vice-president and other senior officials, flew out of the country on Sunday, setting the stage for Taliban insurgents to regain power in Afghanistan, 20 years after a US-led military invasion ousted them.


There was no comment from Ghani or his embattled administration in Kabul. In a recorded message on Saturday, Ghani had told the nation that he was consulting with both national and international players on the situation which he called an "imposed war".


Afghan Vice President Amrullah Saleh, who is said to have accompanied Ghani and the others who left, in a tweet vowed not to bow to the Taliban, but he did not respond in the message to reports of him leaving the country.

MORE International ARTICLES

Extra safety scrutiny planned as virus vaccine worries grow

Extra safety scrutiny planned as virus vaccine worries grow
The poll from The Associated Press-NORC Center for Public Affairs Research found only 46% of Americans want a COVID-19 vaccine and another 29% are unsure.

Extra safety scrutiny planned as virus vaccine worries grow

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout
The COLA affects the personal finances of about 1 in 5 Americans, including Social Security recipients, disabled veterans and federal retirees, some 70 million people in all.

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout

AP-NORC poll: New angst for caregivers in time of COVID-19

AP-NORC poll: New angst for caregivers in time of COVID-19
The Associated Press-NORC Center for Public Affairs Research poll finds that 17% of Americans say they are providing ongoing caregiving, part of an informal volunteer corps.

AP-NORC poll: New angst for caregivers in time of COVID-19

Am I immune to the coronavirus if I’ve already had it?

Am I immune to the coronavirus if I’ve already had it?
Reinfection so far has been rare. The best known example: Researchers in Hong Kong said a man had mild COVID-19 and then months later was infected again but showed no symptoms.

Am I immune to the coronavirus if I’ve already had it?

Antibody drugs are no cure but seem promising for COVID-19

Antibody drugs are no cure but seem promising for COVID-19
Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. Vaccines mimic an infection to spur antibody production.

Antibody drugs are no cure but seem promising for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19
Eli Lilly and Company announced the partial results Wednesday in a news release; they have not yet been published or reviewed by independent scientists.

Lilly seeks emergency use of its antibody drug for COVID-19